Methods for using antagonistic anti-avb3 integrin antibodies

摘要

Monoclonal antibodies that recognize the alphavbeta3 integrin receptor complex, but do not significantly bind to alphaIIbbetaIIIa, can be used in methods for treating alphavbeta3 integrin-mediated diseases, such as tunor metastasis.